7Baggers
 Goldman Sachs Sticks to Its Buy Rating for Argenx Se (ARGX)  The Globe and Mail Fri, 03 Oct 2025 06:27:41 GMT
 Argenx Se (ARGX) Gets a Buy from Morgan Stanley  The Globe and Mail Thu, 02 Oct 2025 00:10:00 GMT
 Morgan Stanley Raises Price Target for ARGX to $1040 While Maint  GuruFocus Wed, 01 Oct 2025 16:36:12 GMT
 Argenx stock hits all-time high at 781.12 USD  Investing.com Wed, 01 Oct 2025 15:51:41 GMT
 Argenx Se (ARGX) Receives a Buy from RBC Capital  The Globe and Mail Tue, 30 Sep 2025 10:50:00 GMT
 are medical stocks lagging argenx (argx) this year?  Yahoo Finance Tue, 23 Sep 2025 07:00:00 GMT
 argenx plunges after q1 revenue miss  MSN Fri, 19 Sep 2025 18:59:33 GMT
 Biotech’s Surge to €38 Billion Value Sends Argenx to Stock Elite  Bloomberg.com Fri, 19 Sep 2025 07:00:00 GMT
 high growth european tech stocks to watch september 2025  simplywall.st Fri, 19 Sep 2025 07:00:00 GMT
 argenx se $argx shares bought by voya investment management llc  MarketBeat Fri, 19 Sep 2025 05:18:25 GMT
 goldman sachs group inc. acquires 21,805 shares of argenx se $argx  MarketBeat Fri, 19 Sep 2025 02:19:27 GMT
 published on: 2025-09-19 00:26:23  خودرو بانک Thu, 18 Sep 2025 20:57:39 GMT
 goldman sachs group inc. acquires 21,805 shares of argenx se $argx  MarketBeat Thu, 18 Sep 2025 19:23:17 GMT
 Argenx Se (ARGX) Receives a Rating Update from a Top Analyst  The Globe and Mail Thu, 18 Sep 2025 07:00:00 GMT
 oppenheimer maintains argenx se(argx.us) with buy rating  富途牛牛 Thu, 18 Sep 2025 07:00:00 GMT
 argenx se $argx shares bought by voya investment management llc  MarketBeat Thu, 18 Sep 2025 07:00:00 GMT
 transcript : argenx se - special call  MarketScreener Tue, 16 Sep 2025 20:20:15 GMT
 wall street analysts are bullish on top healthcare picks  The Globe and Mail Tue, 16 Sep 2025 13:34:00 GMT
 bank of america securities remains a buy on argenx se (argx)  The Globe and Mail Tue, 16 Sep 2025 07:00:00 GMT
 Truist Securities assumes coverage on argenx stock with Buy rating  Investing.com Mon, 15 Sep 2025 07:00:00 GMT
 argenx: Bullish On This R&D Focused Biotech Stock  Seeking Alpha Fri, 12 Sep 2025 07:00:00 GMT
 deutsche bank upgrades argenx se(argx.us) to hold rating  富途牛牛 Thu, 11 Sep 2025 17:39:17 GMT
 argenx SE (ARGX) Expands Autoimmune Leadership with Vyvgart Launch  Yahoo Finance Thu, 11 Sep 2025 07:00:00 GMT
 Bank of America Securities Sticks to Its Buy Rating for Argenx Se (ARGX)  The Globe and Mail Tue, 09 Sep 2025 07:00:00 GMT
 BofA Securities reaffirms Buy rating on argenx stock with $887 target  Investing.com Mon, 08 Sep 2025 07:00:00 GMT
 argenx stock hits all-time high at 716.89 usd by investing.com  Investing.com Australia Thu, 04 Sep 2025 13:37:08 GMT
 what moving averages say about argenx se depositary receipt  Newser Wed, 03 Sep 2025 14:42:51 GMT
 published on: 2025-09-03 02:17:42  Newser Wed, 03 Sep 2025 07:17:42 GMT
 Argenx stock hits all-time high at 716.89 USD  Investing.com Wed, 03 Sep 2025 07:00:00 GMT
 bank of america securities sticks to its buy rating for argen x (0qw0)  The Globe and Mail Wed, 03 Sep 2025 07:00:00 GMT
 argenx price target raised to $887 from $880 at bofa  TipRanks Tue, 02 Sep 2025 12:47:42 GMT
 euro stoxx 50 adds deutsche bank, siemens energy, argenx  MarketScreener Tue, 02 Sep 2025 06:07:19 GMT
 Deutsche Bank to Rejoin Euro Stoxx 50 After Seven-Year Absence  Bloomberg.com Mon, 01 Sep 2025 07:00:00 GMT
 3 healthcare pathbreakers with long-term tailwinds  MarketBeat Mon, 01 Sep 2025 07:00:00 GMT
 published on: 2025-08-31 16:00:38  Newser Sun, 31 Aug 2025 21:00:38 GMT
 published on: 2025-08-31 15:41:56  Newser Sun, 31 Aug 2025 20:41:56 GMT
 published on: 2025-09-03 02:17:42  Newser Sun, 31 Aug 2025 20:05:40 GMT
 published on: 2025-08-30 10:04:14  Newser Sat, 30 Aug 2025 15:04:14 GMT
 published on: 2025-08-29 06:20:46  Newser Fri, 29 Aug 2025 11:20:46 GMT
 published on: 2025-08-29 02:20:05  Newser Fri, 29 Aug 2025 07:20:05 GMT
 published on: 2025-08-28 22:58:26  Newser Fri, 29 Aug 2025 03:58:26 GMT

argenx SE
(NASDAQ:ARGX) 

ARGX stock logo

argenx SE, a clinical-stage biotechnology company, focuses on developing antibody-based therapies for the treatment of autoimmune diseases, hematology, and cancer. It is developing its lead product candidate, efgartigimod, for the treatment of patients with myasthenia gravis; immune thrombocytopenia...

Founded: 2008
Full Time Employees: 186
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends